Xponance Inc. Has $51.73 Million Position in The Procter & Gamble Company (NYSE:PG)

Xponance Inc. boosted its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 5.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 352,997 shares of the company’s stock after acquiring an additional 17,417 shares during the quarter. Procter & Gamble accounts for about 0.6% of Xponance Inc.’s portfolio, making the stock its 21st largest position. Xponance Inc.’s holdings in Procter & Gamble were worth $51,728,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Dfpg Investments LLC boosted its stake in shares of Procter & Gamble by 1.7% in the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after purchasing an additional 424 shares during the last quarter. Garrett Wealth Advisory Group LLC boosted its stake in Procter & Gamble by 6.3% during the third quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock worth $645,000 after acquiring an additional 260 shares in the last quarter. N.E.W. Advisory Services LLC boosted its stake in Procter & Gamble by 14.6% during the third quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock worth $13,772,000 after acquiring an additional 12,016 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Procter & Gamble by 0.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock worth $2,298,184,000 after acquiring an additional 131,339 shares in the last quarter. Finally, Miracle Mile Advisors LLC boosted its stake in Procter & Gamble by 105.5% during the fourth quarter. Miracle Mile Advisors LLC now owns 59,363 shares of the company’s stock worth $8,699,000 after acquiring an additional 30,473 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Activity at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Ma. Fatima Francisco sold 74,443 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the transaction, the chief executive officer now owns 973 shares in the company, valued at approximately $149,160.90. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is owned by insiders.

Procter & Gamble Trading Up 0.9 %

NYSE:PG traded up $1.34 during trading hours on Thursday, hitting $157.29. The company had a trading volume of 7,281,779 shares, compared to its average volume of 6,829,744. The company has a market capitalization of $370.11 billion, a PE ratio of 26.22, a price-to-earnings-growth ratio of 3.19 and a beta of 0.44. The stock has a 50-day moving average price of $159.16 and a 200 day moving average price of $152.80. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $163.14. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.64 and a quick ratio of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, January 23rd. The company reported $1.84 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.14. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm had revenue of $21.44 billion for the quarter, compared to analysts’ expectations of $21.48 billion. During the same quarter in the previous year, the business posted $1.59 EPS. The company’s quarterly revenue was up 3.2% on a year-over-year basis. On average, equities research analysts predict that The Procter & Gamble Company will post 6.45 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.56%. The ex-dividend date of this dividend is Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is currently 62.98%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Royal Bank of Canada upped their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 24th. Wells Fargo & Company increased their target price on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Barclays increased their price target on shares of Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a research report on Friday, April 12th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Procter & Gamble from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $168.53.

Read Our Latest Analysis on Procter & Gamble

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.